Autoreactivity against myelin basic protein in patients with chronic paraplegia

D. Zajarías-Fainsod, J. Carrillo-Ruiz, H. Mestre, I. Grijalva, I. Madrazo, A. Ibarra

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

29 Citas (Scopus)

Resumen

Introduction Previous studies have shown the existence of either cellular or humoral MBP-reactive elements up to 5 years after spinal cord injury (SCI), but not the presence of both after 10 years. Materials and methods Twelve SCI patients, with more than 10 years of evolution, and 18 healthy blood donors were studied. Lymphocyte proliferation (colorimetric- BrdU ELISA assay) and antibody titers against MBP (ELISA Human IgG MBP-specific assay) were assessed. Results SCI patients presented a significant T-cell proliferation against MBP (lymphocyte proliferation index: 3.7 ± 1.5, mean ± SD) compared to control individuals (0.7 ± 0.3; P<0.001). Humoral response analysis yielded a significant difference (P<0.0001) between the antibody titers of controls and SCI patients. A significant correlation between cellular and humoral responses was observed. Finally, patients with an ASIA B presented the highest immune responses. Conclusion This work demonstrates, for the first time, the existence of both cellular and humoral responses against MBP in the chronic stages (>10 years) of injury.

Idioma originalInglés
Páginas (desde-hasta)964-970
Número de páginas7
PublicaciónEuropean Spine Journal
Volumen21
N.º5
DOI
EstadoPublicada - 1 may 2012

Huella

Profundice en los temas de investigación de 'Autoreactivity against myelin basic protein in patients with chronic paraplegia'. En conjunto forman una huella única.

Citar esto